STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry
Recruiting
- Dyslipoproteinemias
- PCSK9 Inhibitor [EPC]
- Standard lipid lowering therapy
- Dresden, GermanyMedizinische Klinik und Poliklinik III
2022-03-18
Mar 18, 2022U
Completed
- Impaired Glucose Tolerance
- Nicotinic acid
- +4 more
- Sherbrooke, Quebec, Canadacentre de recherche du CHUS
2021-11-16
Nov 16, 2021S
Completed
- Hypercholesterolemia
- Alirocumab SAR236553 (REGN727)
- +11 more
- Sao Paulo, Brazil
- +9 more
2020-12-02
Dec 2, 2020S
Active, not recruiting
- Hypercholesterolaemia
- Alirocumab SAR236553 (REGN727)
- +12 more
- Boca Raton, Florida
- +45 more
2022-01-12
Jan 12, 2022U
Completed
- Metabolic Syndrome
- Hypertriglyceridemia
- omega-3 acid ethyl esters
- +3 more
- Sioux Falls, South DakotaSanford Clinic Clinical Research Services
2021-09-28
Sep 28, 2021S
Completed
- Hypercholesterolaemia
- alirocumab SAR236553 (REGN727)
- +6 more
- Saint Louis, Missouri
- +15 more
2019-08-15
Aug 15, 2019U
Completed
- Obesity
- training
- +2 more
- Toulouse, FranceCentre d'Investigation Clinique, Purpan University Toulouse Hosp
2020-07-28
Jul 28, 2020F
Unknown status
- Hand-Foot Skin Reaction (HFSR)
- Nicotinic acid +Routine care
- Routine care
- Hangzhou, Zhejiang, ChinaFirst People's Hospital of Hangzhou
2020-03-31
Mar 31, 2020U
Active, not recruiting
- Alzheimer's Disease
- Mild Cognitive Impairment
- Nicotinamide
- Placebo Comparator
- Irvine, California
- +1 more
2021-11-15
Nov 15, 2021A
Recruiting
- Type 2 Diabetes Mellitus
- +2 more
- Diazoxide
- +2 more
- Bronx, New YorkAlbert Einstein College of Medicine
2021-10-27
Oct 27, 2021M
Completed
- Hypercholesterolemia
- nicotinic acid/laropiprant
- Manchester, United KingdomManchester Royal Infirmary
2020-10-26
Oct 26, 2020U
Recruiting
- Type 2 Diabetes
- Cold exposure
- Oral Nicotinic acid
- Sherbrooke, Quebec, CanadaCentre de recherche du CHUS
2021-10-12
Oct 12, 2021U
Completed
- Mitochondrial Myopathies
- Niacin
- Helsinki, FinlandUniversity of Helsinki
2021-01-21
Jan 21, 2021A
Recruiting
- Skeletal Muscle
- Deuterated nicotinamide (D4-NAM) IV infusion
- +2 more
- Orlando, FloridaAdventHealth Translational Research Institute
2022-02-15
Feb 15, 2022A
Suspended
- Diabetes Mellitus, Type 2
- +2 more
- Diazoxide
- +2 more
- Bronx, New YorkAlbert Einstein College of Medicine
2021-10-27
Oct 27, 2021Q
Completed
- Covid19
- Lymphopenia
- Shenyang, Liaoning, ChinaGeneral Hospital of Northern Theater Command
2021-10-29
Oct 29, 2021M
Recruiting
- Concussion, Mild
- Nicotinamide Riboside
- Matching placebo
- Minneapolis, Minnesota
- +1 more
2022-02-17
Feb 17, 2022P
Not yet recruiting
- Acute Stroke
- Cytoflavin (succinic acid + inosine + nicotinamide + riboflavin)
- Control
- (no location specified)
2022-03-17
Mar 17, 2022F
Recruiting
- Hypertension
- Nicotinamide mononucleotide supplied as 400mg capsule
- Lifestyle modification
- Guangzhou, Guangdong, ChinaFirst Affiliated Hospital,Sun Yat-sen University
2022-01-17
Jan 17, 2022U
Completed
- Dyslipidemia
- ER Niacin Oral Fat Challenge
- +2 more
- Philadelphia, Pennsylvania
- +1 more
2020-07-08
Jul 8, 2020M
Completed
- Neuralgia
- Myalgia
- Cunermuspir
- Placebo
- London, Ontario, CanadaKGK Synergize now KGK Science
2021-03-24
Mar 24, 2021T
Completed
- Plaque Psoriasis
- Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045%
- +2 more
- Charlotte, North CarolinaCatawba Research, LLC
2022-03-15
Mar 15, 2022C
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Exercise Intervention
- Nicotinamide Riboside
- Duarte, CaliforniaCity of Hope Medical Center
2022-02-16
Feb 16, 2022S
Active, not recruiting
- Healthy Volunteers
- Nicotinamide mononucleotide (NMN-C)
- Dijon, FranceBiomed 21
2021-12-13
Dec 13, 2021U
Active, not recruiting
- Dyslipidemia
- Krill Oil
- +4 more
- Davis, CaliforniaUC Davis, Ragle Human Nutrition Center
2021-08-09
Aug 9, 2021